2026 Akero Therapeutics, Inc.
akerotx.com
Actively hiring
Cardiometabolic Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
Apple Tree Partners, Atlas Venture
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Apple Tree Partners 
Atlas Venture 
venBio Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Refoxy Pharmaceuticals GmbH is a pre-clinical biotech company developing FOXO3-targeting therapies to restore cellular balance and treat…
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment.
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. Terrestrial.
News
Investor highlights - Get an overview of our investor services
Here you will get an overview of all the information and services that we provide for you as a Novo Nordisk investors.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
601 Gateway Boulevard Suite 350 South San Francisco, CA 94080
601 Gateway Boulevard Suite 350 South San Francisco, CA 94080